section name header

Indications

REMS

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: QT interval prolongation, palpitations, TORSADES DE POINTES.

EENT: tinnitus.

GI: abdominal pain, constipation, dry mouth, nausea, vomiting.

GU: acute renal failure.

Neuro: dizziness, headache.

Interactions

Drug-Drug:

Drug-Natural Products:

Drug-Food:

Availability

(Generic available)

Route/Dosage

US Brand Names

Aspruzyo Sprinkle, Ranexa

Action

Therapeutic Effects:

Classifications

Therapeutic Classification: antianginals

Pharmacokinetics

Absorption: Highly variable.

Distribution: Unknown.

Metabolism/Excretion: Metabolized by the liver primarily by the CYP3A isoenzyme and to a lesser extent by the CYP2D6 isoenzyme; <5% excreted unchanged in urine and feces.

Half-life: 7 hr.

Canadian Brand Names

Corzyna

Time/Action Profile

(plasma concentrations)

ROUTEONSETPEAKDURATION
POunknown2–5 hr12 hr

Patient/Family Teaching

Pronunciation

ra-NOLE-a-zeen audio

Code

NDC Code*